Elisabeth Heere‐Ress

1.4k total citations
21 papers, 1.1k citations indexed

About

Elisabeth Heere‐Ress is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Elisabeth Heere‐Ress has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Oncology. Recurrent topics in Elisabeth Heere‐Ress's work include RNA Interference and Gene Delivery (4 papers), Melanoma and MAPK Pathways (3 papers) and Mast cells and histamine (3 papers). Elisabeth Heere‐Ress is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Melanoma and MAPK Pathways (3 papers) and Mast cells and histamine (3 papers). Elisabeth Heere‐Ress collaborates with scholars based in Austria, Canada and Netherlands. Elisabeth Heere‐Ress's co-authors include Hubert Pehamberger, Burkhard Jansen, Hermine Schlagbauer‐Wadl, Volker Wacheck, Trevor Lucas, Christoph Höeller, K. Wolff, Ursula Hollenstein, Klaus Wolff and Christiane Thallinger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Cancer.

In The Last Decade

Elisabeth Heere‐Ress

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Heere‐Ress Austria 16 732 402 231 96 84 21 1.1k
Carl V. Hamby United States 16 545 0.7× 311 0.8× 228 1.0× 128 1.3× 106 1.3× 39 1.0k
Marcia A. Munoz Australia 17 608 0.8× 440 1.1× 181 0.8× 91 0.9× 52 0.6× 22 1.1k
Bharvin K.R. Patel United States 17 623 0.9× 560 1.4× 259 1.1× 43 0.4× 78 0.9× 29 1.1k
Apollina Goel United States 18 639 0.9× 258 0.6× 138 0.6× 127 1.3× 102 1.2× 23 1.1k
Susan Swift United States 14 428 0.6× 243 0.6× 281 1.2× 66 0.7× 63 0.8× 20 1.1k
Keiichi I. Nakayama Japan 14 745 1.0× 336 0.8× 188 0.8× 99 1.0× 45 0.5× 22 1.2k
Naoki Watanabe Japan 21 527 0.7× 220 0.5× 380 1.6× 80 0.8× 103 1.2× 72 1.2k
Federica Catalanotti United States 11 615 0.8× 258 0.6× 382 1.7× 75 0.8× 128 1.5× 15 1.2k
S. Peter Klinken Australia 18 556 0.8× 209 0.5× 220 1.0× 112 1.2× 44 0.5× 34 1.0k
Christine Wagner Austria 19 497 0.7× 392 1.0× 391 1.7× 96 1.0× 68 0.8× 41 1.0k

Countries citing papers authored by Elisabeth Heere‐Ress

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Heere‐Ress's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Heere‐Ress with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Heere‐Ress more than expected).

Fields of papers citing papers by Elisabeth Heere‐Ress

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Heere‐Ress. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Heere‐Ress. The network helps show where Elisabeth Heere‐Ress may publish in the future.

Co-authorship network of co-authors of Elisabeth Heere‐Ress

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Heere‐Ress. A scholar is included among the top collaborators of Elisabeth Heere‐Ress based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Heere‐Ress. Elisabeth Heere‐Ress is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tzaneva, Stanislava, et al.. (2014). Surgical Treatment of Large Vascular Leg Ulcers. Dermatologic Surgery. 40(11). 1240–1248. 11 indexed citations
2.
Heere‐Ress, Elisabeth, Volker Wacheck, Stanislava Tzaneva, et al.. (2011). Does Endovenous Laser Ablation Induce Endothelial Damage at the Saphenofemoral Junction?. Dermatologic Surgery. 37(10). 1456–1463. 1 indexed citations
3.
Höeller, Christoph, Christiane Thallinger, Barbara Pratscher, et al.. (2005). The Non-Receptor-Associated Tyrosine Kinase Syk is a Regulator of Metastatic Behavior in Human Melanoma Cells. Journal of Investigative Dermatology. 124(6). 1293–1299. 39 indexed citations
4.
Heere‐Ress, Elisabeth, Johannes Boehm, Christiane Thallinger, et al.. (2005). Thalidomide Enhances the Anti-Tumor Activity of Standard Chemotherapy in a Human Melanoma Xenotransplatation Model. Journal of Investigative Dermatology. 125(2). 201–206. 15 indexed citations
5.
Valencak, Julia, Elisabeth Heere‐Ress, Tatjana Traub‐Weidinger, et al.. (2005). Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results. Melanoma Research. 15(6). 523–529. 10 indexed citations
6.
Seltenhammer, Monika, Elisabeth Heere‐Ress, Sabine Brandt, et al.. (2004). Comparative Histopathology of Grey‐Horse‐Melanoma and Human Malignant Melanoma. Pigment Cell Research. 17(6). 674–681. 56 indexed citations
7.
Valencak, Julia, Susana Ortiz‐Urda, Elisabeth Heere‐Ress, Rainer Kunstfeld, & Wolfgang Base. (2003). Carbamazepine‐induced DRESS syndrome with recurrent fever and exanthema. International Journal of Dermatology. 43(1). 51–54. 17 indexed citations
8.
Valencak, Julia, Elisabeth Heere‐Ress, Tamara Kopp, et al.. (2003). Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. European Journal of Cancer. 40(3). 358–364. 50 indexed citations
9.
Häfner, Christine, Ursula Föger‐Samwald, Stephan N. Wagner, et al.. (2002). Selection of Mimotopes of the Cell Surface Adhesion Molecule Mel-CAM from a Random pVIII-28aa Phage Peptide Library. Journal of Investigative Dermatology. 119(4). 865–869. 10 indexed citations
10.
Selzer, Edgar, Volker Wacheck, Trevor Lucas, et al.. (2002). The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma.. PubMed. 62(7). 2098–103. 60 indexed citations
11.
Heere‐Ress, Elisabeth, Christiane Thallinger, Trevor Lucas, et al.. (2002). Bcl‐XL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy. International Journal of Cancer. 99(1). 29–34. 70 indexed citations
12.
Wacheck, Volker, Clemens Krepler, Sabine Strommer, et al.. (2002). Antitumor Effect of G3139 Bcl-2 Antisense Oligonucleotide Is Independent of Its Immune Stimulation by CpG Motifs in SCID Mice. Antisense and Nucleic Acid Drug Development. 12(6). 359–367. 26 indexed citations
13.
Joukhadar, Christian, Nikolas Klein, Robert M. Mader, et al.. (2001). Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma. Cancer. 92(8). 2190–2196. 19 indexed citations
14.
Höeller, Christoph, Burkhard Jansen, Elisabeth Heere‐Ress, et al.. (2001). Perilesional Injection of r-GM-CSF in Patients with Cutaneous Melanoma Metastases. Journal of Investigative Dermatology. 117(2). 371–374. 33 indexed citations
15.
Wacheck, Volker, Elisabeth Heere‐Ress, Julius Halaschek-Wiener, et al.. (2001). Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model. Journal of Molecular Medicine. 79(10). 587–593. 51 indexed citations
16.
Schlagbauer‐Wadl, Hermine, Gabriele Klosner, Elisabeth Heere‐Ress, et al.. (2000). Bcl-2 Antisense Oligonucleotides (G3139) Inhibit Merkel Cell Carcinoma Growth in SCID Mice. Journal of Investigative Dermatology. 114(4). 725–730. 74 indexed citations
17.
Jansen, Burkhard, Volker Wacheck, Elisabeth Heere‐Ress, et al.. (2000). Chemosensitisation of malignant melanoma by BCL2 antisense therapy. The Lancet. 356(9243). 1728–1733. 379 indexed citations
18.
Jansen, Burkhard, Hermine Schlagbauer‐Wadl, Heike Kahr, et al.. (1999). Novel Ras antagonist blocks human melanoma growth. Proceedings of the National Academy of Sciences. 96(24). 14019–14024. 83 indexed citations
19.
20.
Jansen, Burkhard, Elisabeth Heere‐Ress, Hermine Schlagbauer‐Wadl, et al.. (1999). Farnesylthiosalicylic acid inhibits the growth of human Merkel cell carcinoma in SCID mice. Journal of Molecular Medicine. 77(11). 792–797. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl V. Hamby Breakdown of academic impact, for papers by Marcia A. Munoz Breakdown of academic impact, for papers by Bharvin K.R. Patel Breakdown of academic impact, for papers by Apollina Goel Breakdown of academic impact, for papers by Susan Swift Breakdown of academic impact, for papers by Keiichi I. Nakayama Breakdown of academic impact, for papers by Naoki Watanabe Breakdown of academic impact, for papers by Federica Catalanotti Breakdown of academic impact, for papers by S. Peter Klinken Breakdown of academic impact, for papers by Christine Wagner
Rankless by CCL
2026